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Results: At baseline (BL) CTX-I and CTX-II were linearly correlated in
the healthy population (r = 0.52, p< 0.001) but only borderline for the OA
subjects (r = 0.29, p = 0.09) (Figure 1).
There was a linear correlation between BL CTX-II scores and follow-
up (FU) CTX-I (r = 0.23, p< 0.01). Contrarily, there was no correlation
between BL CTX-I and FU CTX-II (r = 0.08, p = 0.4).
Inspection of the healthy subjects showed that elevated CTX-II scores
at BL predicted longitudinal cartilage loss. Speciﬁcally, the odds ratio
(OR) for increased cartilage loss was 4.0 – comparing highest and lowest
tertiles of CTX-II (p< 0.01). For CTX-I, the BL scores were not signiﬁcantly
indicative of cartilage loss (Figure 2). All results persisted after correction
for gender and age.
Figure 2.
Conclusions: The results support that a balanced cartilage and bone
turnover may be of major importance for joint health, and that distabi-
lization of this delicate equilibrium may be a catalyst for initiation and
progression of OA. This emphasizes a potential need for OA treatments
that restore the bone/cartilage metabolic balance. By comparison of BL
and FU biomarker levels, it could be hypothesized that at least a speciﬁc
stage of cartilage breakdown (elevated CTX-II at BL) is preceding bone
remodeling (elevated CTX-I at FU) in OA. This may provide a piece for
the complex puzzle of causal relationships between cartilage and bone
breakdown.
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Purpose: In normal adult cartilage there is a balance between synthesis
and degradation of extra cellular matrix components. In diseases such as
OA this balance is disturbed. MMPs and aggrecanases (i.e. ADAMTS-4,
-5) are the major enzymes involved in cartilage degradation. Proteolytic
cleavage of aggrecan is seen at early stage of OA and in knee injuries.
Several reports suggest aggrecanases to be the enzymes responsible
for this degradation. ADAMTS-4 cleaves aggrecan at speciﬁc sites in the
interglobular domain (TEGE ↓ARGS) and in the chondroitinsulphate (CS)
rich region 2 (SELE ↓GRGT, KEEE ↓GLGS, TAQE ↓AGEG and ISQE ↓
LGQR). To understand the process of cartilage degradation it is important
to know in which order the enzymes cleaves aggrecan. The present study
was undertaken to investigate the time dependent degradation of human
aggrecan monomers by ADAMTS-4.
Methods: Human aggrecan was puriﬁed from a pool of total knee OA-
cartilage (n = 10, from knee replacement surgery) by guanidine extraction
and CsCl density gradient centrifugation, collecting the aggrecan in the
A1D1 fraction. Aggrecan (42 nM) was digested by recombinant human
ADAMTS-4 (1 nM) up to 24 h at 37ºC. Samples were deglycosylated,
separated by SDS-PAGE, transferred to PVDF membranes, and probed
by neoepitope antibodies (ARGS, SELE, KEEE, and LGQR) and antibod-
ies against aggrecan G3 and G1 domains. Immunodetected aggrecan
fragments were quantiﬁed using chemiluminescence and digital lumines-
cence imager.
Results: The A1D1 fraction extracted from human joint cartilage lacks
ARGS fragments and low molecular weight G3 fragments (GRGT, GLGS,
AGEG and LGQR-G3), but contain G1-G3 monomers, G1-SELE/KEEE
and G1-CS1 fragments which serve as substrates for ADAMTS-4 in
the beginning of the digestion. After 15min of digestion all the G1-G3
monomers were degraded and G1-SELE/KEEE and GRGT/GLGS-G3
fragments were produced (see ﬁgure). After 2 h these fragments could
only be detected at 10% of maximum concentration. The AGEG-G3
fragments reached maximum concentration after 1 h and then slowly
decreased to 10% level at 24 h. The GRGT-KEEE fragment reached a
maximum concentration after 1 h, and thereafter decreased slowly. The
ARGS-SELE and ARGS-CS1 fragments increased with similar kinetics
up to 80% of maximum concentration within 30min and thereafter slowly
increased to a maximum concentration at 4 h digestion. The production
of the LGQR-G3 fragment was slow, reaching maximum after 12 h.
Time dependent ADAMTS-4 in vitro digestion of human aggrecan moni-
tored by Western blot.
Conclusions: These results suggest that ADAMTS-4 cleaves aggrecan
ﬁrst in the KEEE ↓GLGS site, closely followed in time by cleavages in the
SELE ↓GRGT, TEGE ↓ARGS and the TAQE ↓AGEG sites. The cut in the
ISQE ↓ LGQR site seems to be the last preferred cleavage site for the
enzyme.
The data show that aggrecan monomers, puriﬁed from OA cartilage, can
be further digested by ADAMTS-4 suggesting it to be a relevant sample
for aggrecan degradation studies. The aggrecan fragments detected in
this study have also been detected in synovial ﬂuids from patients with
arthritis and knee injuries, suggesting that these in vitro digestions reﬂect
conditions found in vivo.
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Purpose: Cartilage oligomeric matrix protein (COMP) is a pentameric
glycoprotein related to thrombospondin family and found predominantly
in cartilage. Increased levels of COMP have been detected in patients
with various degenerative and inﬂammatory joint diseases and have been
correlated with accelerated joint damage. Aim of our study was to assess
the hypothesis that there’s a signiﬁcant correlation between COMP serum
levels, joint radiological damage and clinical severity in patients with hand
osteoarthritis (OA).
Methods: 54 patients with hand OA referring to Rheumatology Unit of
our Hospital were enrolled in 2007. COMP serum values were measured
by inhibition ELISA with monoclonal antibody. Radiographs were evalu-
ated according to the grading system of Kellgren and Lawrence by an
experienced rheumatologist. Patient’s pain was assessed with a visual
analogue scale (VAS 0–100mm).
Results: We enrolled 54 patients (45 with primary OA of the hand and
9 with erosive OA of the hand). In the whole population the COMP,
VAS and radiological score mean values were 11.49 (range 5.79−33,
SD 5.5), 25.3 (range 0−75 SD 18.3) and 38.8 (range 18−65, SD 9.8)
respectively. Patients with symptomatic hand OA (arbitrary cut-off set to
VAS 30) presented signiﬁcantly higher serum COMP levels compared to
those with non-symptomatic narrowing of the articular space (27.4±2.1
vs 11.4±5, p = 0.011), with a Pearson correlation index between VAS
and COMP values of 0.31 (95%CI: 0.22−0.67, p = 0.02). Furthermore, a
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signiﬁcant correlation has been observed between radiological damage
index and COMP levels, with a Pearson correlation index of 0.45 (95%CI:
0.32−0.64, p = 0.018).
Conclusions: We observed increased serum COMP levels in patients
with symptomatic radiological hand OA. Higher serum COMP levels
seems to correlate to more aggressive and severe disease, in terms of
pain (VAS values) and radiologic damage (Kellgren and Lawrence index).
92 EVALUATION OF THE USEFULNESS OF BIOMARKERS IN
KNEE OSTEOARTHRITIS OR LUMBAR SPONDYLOSIS IN
MASS COHORT STUDY OF JAPAN
M. Morita1, H. Yamada1, N. Yoshimura2, H. Date1, H. Oka2, S. Muraki3,
T. Akune3, H. Ichinose1, H. Kawaguchi4, K. Nakamura4. 1Department
of Orthopaedic Surgey, Fujita Health University, Toyoake, JAPAN,
2Department of Joint Disease Research, 22nd Century Medical
and Research Center, University of Tokyo Hospital, Tokyo, JAPAN,
3Department of Clinical Motor System Medicine, 22nd Century Medical
and Research Center, University of Tokyo Hospital, Tokyo, JAPAN,
4Sensory and Motor System Medicine, Faculty of Medicine, University
of Tokyo, Postgraduated school of medicine, Tokyo, JAPAN
Purpose: It is socially required to establish the correlation of some spe-
ciﬁc biomarkers and the clinical stage of osteoarthritis (OA) or spondylosis
(SP). The aim of this study is to evaluate the usefulness of some serum
or urine biomarkers in OA or SP in the large population cohort study of
Japan.
Methods: Eight hundred and sixty four peoples (319 males and 544 fe-
males) over ﬁfty-year-old at the area of Hidakagawa-cho (Wakayama
prefecture) and Taichi-cho (Same) were the target of this study. Radio-
logical grade were estimated with Kellgren and Lawrence (K-L) grade.
Serum levels of cartilage oligomeric matrix protein (COMP), urinary
levels of CTX-I and CTX-II were measured and analysed to evaluate
the correlation of knee OA or SP.
Results: Prevalence of knee OA was 56.3% and lumbar SP was 62.6%.
Clinical stage of knee OA was that 79 in grade 0, 279 in grade 1, 359 in
grade 2, 97 in grade 3, 50 in grade 4. Clinical stage of SP was that 39 in
grade 0, 282 in grade 1, 275 in grade 2, 166 in grade 3, 102 in grade 4.
Serum levels of COMP and urine levels of CTX-II were both positively
correlated with the clinical stage of knee OA or lumbar SP (p< 0.0001)
in the analysis of covariance (ANCOVA). There was no correlation in
urinary levels of CTX-I and the radiological severity of knee OA or lumbar
SP. There was no correlation among COMP, CTX-I or CTX-II.
Conclusions: Serum levels of COMP and urinary levels of CTX-II were
usuful to evaluate the clinical stage of knee OA or lumbar SP. Biomarkers
in serum or urine were easy to collect and simple to estimate the clinical
evaluation of OA or SP.
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Purpose: Recent animal studies have suggested that Dkk-1, a secreted
inhibitor of Wnt signaling pathway, could play an important role in medi-
ating the alterations of joint tissue turnover associated with rheumatoid
arthritis (RA) and osteoarthritis (OA), but the clinical relevance of these
ﬁndings remain unclear. The aim of this study was to analyze the
associations between circulating Dkk-1 and cartilage and synovial tissue
turnover in patients with RA and knee OA.
Methods: We measured circulating Dkk-1 by a new sensitive two
site ELISA using antibodies raised against synthetic sequences of hu-
man Dkk-1 in 55 patients with active RA (65% women mean age:
55.4±14.1 yr, median disease duration 11 yr), 85 patients with painful
knee OA (74% women; mean age: 62.8±7.7 yr; radiological Kellgren
Lawrence score II-III, median disease duration: 41.5 months) and 93
healthy controls. Cartilage tissue degradation was evaluated by the
measurement of circulating levels of the type II collagen helical fragment
(Helix-II) and the type II collagenase neoepitope Col2:3/4Clongmono (C2C).
Synovial tissue metabolism was assessed by circulating levels of the
nitrosylated form of type III collagen N-telopeptide (IIINys).
Results: Compared to healthy sex and age matched controls, circulating
Dkk-1 levels were on average 83% higher (p< 0.0001) in patients with
RA, but 37% (p< 0.0001) lower in subjects with knee OA. In patients with
RA, Dkk-1 were positively associated with Helix-II (r = 0.48, p = 0.0018)
and IIINys (r = 0.28, p = 0.04) levels. Conversely, Dkk-1 levels negatively
correlated with C2C (r = −0.23, p = 0.035) in patients with knee OA.
Conclusions: Higher circulating Dkk-1 is associated with increased car-
tilage degradation and synovial tissue turnover in RA, but lower cartilage
destruction in patients with knee OA. These clinical data support the role
of Dkk-1 in joint damage in both RA and OA, with possible divergent
effects.
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Purpose: To examine the relationship between baseline angiogenic
biomarkers and disease activity in knee OA and to determine whether
treatment with an autologous Preparation Rich in Growth Factors (PRGF)
obtained from the patient’s own blood modulates speciﬁc angiogenic
biomarkers in synovial ﬂuid.
Methods: We performed a prospective longitudinal study comprising
a cohort of 81 symptomatic idiopathic or secondary knee OA patients
presenting with joint effusion. Patients were treated with a series of
three weekly intra-articular injections of autologous PRGF, which is
leukocyte-free plasma that is moderately enriched in platelets (2−3 fold
the levels found in peripheral blood). Synovial ﬂuid (SF) was aspirated
as part of the therapeutic procedure. ELISAs were used to determine
the levels of VEGF-A, HGF, and TGF-b1 in synovial ﬂuid before and
during the treatment. Response to PRGF treatment was deﬁned as a
reduction greater than 20% from baseline to week ﬁve post-treatment in
WOMAC sub-scales for pain, rigidity, and function. Spearman correlations
were computed to determine the relationship between baseline levels of
VEGF-A, HGF, and TGF-b1 and clinical variables including age, BMI,
Ahlba¨ck grade, and baseline WOMAC sub-scales. Pearson correlations
were also used to examine relationships between baseline biomarkers
and clinical variables. Improvement percentages for each of the WOMAC
sub-scales were analysed at 5 weeks post-treatment. Multivariate logistic
regression was used to examine factors that could affect the response
to PRGF treatment. The model contained all variables: demographic,
clinical and synovial ﬂuid angiogenic markers. The predictive values are
presented as odds ratios (OR) with 95% conﬁdence intervals (CI) and
probability values.
Results: The mean age was 65 years (range: 44−80), 54% of the
patients were females, and BMI was 28±3.5 kg/m2 (range: 22−38). The
percentage of patients who achieved >20% and >40% reduction in clinical
features according to WOMAC subscales was 19.8% and 35.8% for pain,
15.8% and 38.2% for rigidity, and 22.2% and 19.8% for function.
Baseline levels of angiogenic biomarkers were: VEGF-A: 941±483 pg/ml;
HGF: 884±589 pg/ml and TGF-b1: 860±1032 pg/ml. Correlations were
observed between TGF-b1 and VEGF (0.495, p< 0.001), TGF-b1 and
HGF (0.628, p< 0.001), and VEGF and HGF (0.469, p = 0.001). VEGF
was associated with Ahlba¨ck grade (0.295, p = 0.011). The levels of TGF-
b1 were associated with baseline rigidity and function WOMAC subscales,
Pearson coefﬁcients 0.233, p = 0.038 (rigidity) and 0.250, p = 0.030 (func-
tion). Baseline HGF was associated with function 0.287, p = 0.013.
ANCOVA analysis showed that VEGF levels, when adjusted for age, were
modiﬁed in response to PRGF treatment (p = 0.008).
After considering demographic, clinical, and biological factors in the
regression analyses, the variables signiﬁcantly involved in pain reduc-
tion were changes in VEGF during treatment (OR=1.040, CI = 1.008 to
1.072; p = 0.013) in conjunction with sex (OR=0.152, CI = 0.03 to 0.767;
p = 0.023). It is also noteworthy that we observed a weak association
of baseline TGF-b1 with pain reduction (OR=0.999, CI = 0.998 to 1.000;
p = 0.091). The variables signiﬁcantly involved in rigidity reduction (>20%)
were baseline pain (OR=0.858, CI = 0.745 to 0.988; p = 0.033) in conjunc-
tion with baseline HGF (OR=0.997, CI = 0.994 to 0.999; p = 0.010).
Conclusions: The complexity of OA requires novel approaches that iden-
tify angiogenic biomarkers and their relationship with joint homeostasis
and disease activity.
